The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
The Molecular Basis of Leukemia
Abstract
Major strides have been made in our understanding of the molecular basis of adult and pediatric leukemias. More than one hundred disease alleles have been identified and characterized in cell culture and murine models of leukemia. In some instances, molecularly targeted therapies have been developed based on these insights that are currently in clinical trials, such as small molecule inhibitors of FLT3. In addition, it has recently been appreciated that, as with normal hematopoiesis, there is a hierarchical organization among leukemic cells that includes a rare population of leukemic stem cells that have properties of self-renewal. Understanding the characteristics of these leukemic stem cells may provide new insights into leukemia therapies that target self-renewal pathways. In Section I, Dr. Craig Jordan reviews the data that supports the existence of a “leukemia stem cell.” He provides an overview of the functional properties of leukemic stem cells, their relationship to hematopoietic stem cells, and the relevance of leukemic stem cells in other human malignancies including solid tumors. He briefly discusses what is known of the pathways that regulate properties of self-renewal. Dr. Gary Gilliland provides an overview of the genetics of adult leukemias in Section II and ongoing genome-wide strategies for discovery of new disease alleles. He describes the clinical and therapeutic implications of these findings and provides examples of bench-to-bedside translation of molecularly targeted therapies for AML, including the use of FLT3 inhibitors. In Section III, Dr. Carolyn Felix reviews recent advances in our understanding of the genetics and therapy of pediatric leukemias. She provides an overview of leukemias that are common in pediatric malignancies but rarely observed in adults, including the TEL-AML1 (ETV6-RUNX1) fusion associated with pediatric B-cell ALL, the OTT-MAL fusion associated with infant megakaryoblastic leukemia, PTPN11 mutations in juvenile myelomonocytic leukemia, and MLL fusion genes in leukemogenesis, among others.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713
Daley, G. Q., Van Etten, R. A., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 1,756
The roles of FLT3 in hematopoiesis and leukemia
Gilliland, D. G., & Griffin, J. D. (2002) · Blood · doi:10.1182/blood-2002-02-0492 · Cited by 1,558
Self-citationGraham, S. M., Jørgensen, H. G., Allan, E., Pearson, C., Alcorn, M. J., Richmond, L., & Holyoake, T. L. (2002) · Blood · doi:10.1182/blood.v99.1.319 · Cited by 1,181
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Self-citationTartaglia, M., Niemeyer, C. M., Fragale, A., Song, X., Buechner, J., Jung, A., Hählen, K., Hasle, H., Licht, J. D., & Gelb, B. D. (2003) · Nature Genetics · doi:10.1038/ng1156 · Cited by 1,033
Hope, K. J., Jin, L., & Dick, J. E. (2004) · Nature Immunology · doi:10.1038/ni1080 · Cited by 968
The role of FLT3 in haematopoietic malignancies
Stirewalt, D. L., & Radich, J. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1169 · Cited by 865
Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man
Hollman, P. C. H., van Trijp, J. M. P., Buysman, M. N. C. P., v.d. Gaag, M. S., Mengelers, M. J. B., de Vries, J. H. M., & Katan, M. B. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01367-7 · Cited by 782
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
Guzman, M. L., Neering, S. J., Upchurch, D., Grimes, B., Howard, D. S., Rizzieri, D. A., Luger, S. M., & Jordan, C. T. (2001) · Blood · doi:10.1182/blood.v98.8.2301 · Cited by 758
Self-citationCozzio, A., Passegué, E., Ayton, P. M., Karsunky, H., Cleary, M. L., & Weissman, I. L. (2003) · Genes & Development · doi:10.1101/gad.1143403 · Cited by 663
Weisberg, E., Boulton, C., Kelly, L. M., Manley, P., Fabbro, D., Meyer, T., Gilliland, D. G., & Griffin, J. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00069-7 · Cited by 599
Self-citationHamann, P. R., Hinman, L. M., Hollander, I., Beyer, C. F., Lindh, D., Holcomb, R., Hallett, W., Tsou, H.-R., Upeslacis, J., Shochat, D., et al. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010021y · Cited by 594
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
Burden, D. A., & Osheroff, N. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00132-8 · Cited by 503
Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins
Ayton, P. M., & Cleary, M. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204639 · Cited by 500
Ilaria, R. L., & Van Etten, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31704 · Cited by 488
Kelly, L. M., Liu, Q., Kutok, J. L., Williams, I. R., Boulton, C. L., & Gilliland, D. G. (2002) · Blood · doi:10.1182/blood.v99.1.310 · Cited by 487
Self-citationA FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo
Levis, M., Allebach, J., Tse, K.-F., Zheng, R., Baldwin, B. R., Smith, B. D., Jones-Bolin, S., Ruggeri, B., Dionne, C., & Small, D. (2002) · Blood · doi:10.1182/blood.v99.11.3885 · Cited by 475
Higuchi, M., O'Brien, D., Kumaravelu, P., Lenny, N., Yeoh, E.-J., & Downing, J. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00016-8 · Cited by 440
A PMLRAR α transgene initiates murine acute promyelocytic leukemia
Brown, D., Kogan, S., Lagasse, E., Weissman, I., Alcalay, M., Pelicci, P. G., Atwater, S., & Bishop, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2551 · Cited by 434
Preferential induction of apoptosis for primary human leukemic stem cells
Guzman, M. L., Swiderski, C. F., Howard, D. S., Grimes, B. A., Rossi, R. M., Szilvassy, S. J., & Jordan, C. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252462599 · Cited by 426
Self-citationPui, C.-H., Gaynon, P. S., Boyett, J. M., Chessells, J. M., Baruchel, A., Kamps, W., Silverman, L. B., Biondi, A., Harms, D. O., Vilmer, E., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08782-2 · Cited by 399
Armstrong, S. A., Kung, A. L., Mabon, M. E., Silverman, L. B., Stam, R. W., Den Boer, M. L., Pieters, R., Kersey, J. H., Sallan, S. E., Fletcher, J. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00003-5 · Cited by 398
Acute promyelocytic leukemia: evolving therapeutic strategies
Tallman, M. S., Nabhan, C., Feusner, J. H., & Rowe, J. M. (2002) · Blood · doi:10.1182/blood.v99.3.759 · Cited by 398
Osato, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T., Suzushima, H., Takatsuki, K., Kanno, T., Shigesada, K., et al. (1999) · Blood · doi:10.1182/blood.v93.6.1817.406k36_1817_1824 · Cited by 397
Survival of acute myeloid leukemia cells requires PI3 kinase activation
Xu, Q., Simpson, S.-E., Scialla, T. J., Bagg, A., & Carroll, M. (2003) · Blood · doi:10.1182/blood-2002-11-3429 · Cited by 394
Topoisomerase II as a target for anticancer drugs: When enzymes stop being nice
Fortune, J. M., & Osheroff, N. (2000) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(00)64006-0 · Cited by 366
Grisolano, J. L., Wesselschmidt, R. L., Pelicci, P. G., & Ley, T. J. (1997) · Blood · doi:10.1182/blood.v89.2.376 · Cited by 352
Acute leukemia with promyelocytic features in PML/RARα transgenic mice
He, L.-Z., Tribioli, C., Rivi, R., Peruzzi, D., Pelicci, P. G., Soares, V., Cattoretti, G., & Pandolfi, P. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5302 · Cited by 339
Wiemels, J. L., Smith, R. N., Taylor, G. M., Eden, O. B., Alexander, F. E., Greaves, M. F., & United Kingdom Childhood Cancer Study Investigators (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061408298 · Cited by 339
Raimondi, S. C., Chang, M. N., Ravindranath, Y., Behm, F. G., Gresik, M. V., Steuber, C. P., Weinstein, H. J., & Carroll, A. J. (1999) · PubMed · doi:10.1182/blood.v94.11.3707 · Cited by 323
PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model
Kelly, L. M., Kutok, J. L., Williams, I. R., Boulton, C. L., Amaral, S. M., Curley, D. P., Ley, T. J., & Gilliland, D. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122233699 · Cited by 322
Self-citationCT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)
Kelly, L. M., Yu, J.-C., Boulton, C. L., Apatira, M., Li, J., Sullivan, C. M., Williams, I., Amaral, S. M., Curley, D. P., Duclos, N., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00070-3 · Cited by 305
Self-citationTransplacental chemical exposure and risk of infant leukemia with MLL gene fusion.
Alexander, F. E., Patheal, S. L., Biondi, A., Brandalise, S. R., Cabrera, M. E., Chan, L., Chen, Z., Cimino, G. G., Córdoba, J. C., Gu, L. J., et al. (2001) · PubMed · Cited by 297
Guan, Y., Gerhard, B., & Hogge, D. E. (2003) · Blood · doi:10.1182/blood-2002-10-3062 · Cited by 293
Costello, R. T., Mallet, F., Gaugler, B., Sainty, D., Arnoulet, C., Gastaut, J., & Olive, D. (2000) · PubMed · Cited by 287
Schwaller, J., Frantsve, J., Aster, J., Williams, I. R., Tomasson, M. H., Ross, T. S., Peeters, P., Van Rompaey, L., Van Etten, R. A., Ilaria, R., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.18.5321 · Cited by 245
Self-citationPieters, R., den Boer, M., Durian, M., Janka, G., Schmiegelow, K., Kaspers, G., van Wering, E., & Veerman, A. (1998) · Leukemia · doi:10.1038/sj.leu.2401129 · Cited by 245
Catalytic inhibitors of DNA topoisomerase II
Andoh, T., & Ishida, R. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00133-x · Cited by 231
Ross, J. A., Potter, J. D., Reaman, G. H., Pendergrass, T. W., & Robison, L. L. (1996) · Cancer Causes and Control · doi:10.1007/bf00051700 · Cited by 219
A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9
Dash, A. B., Williams, I. R., Kutok, J. L., Tomasson, M. H., Anastasiadou, E., Lindahl, K., Li, S., Van Etten, R. A., Borrow, J., Housman, D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102583199 · Cited by 209
Self-citationBonnet, D., Warren, E. H., Greenberg, P. D., Dick, J. E., & Riddell, S. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8639 · Cited by 209
Molecular genetics of human leukemias: New insights into therapy
Gilliland, D. G. (2002) · Seminars in Hematology · doi:10.1053/shem.2002.36921 · Cited by 203
Self-citationStam, R. W. (2002) · Blood · doi:10.1182/blood-2002-05-1600 · Cited by 203
Levis, M., Tse, K.-F., Smith, B. D., Garrett, E., & Small, D. (2001) · Blood · doi:10.1182/blood.v98.3.885 · Cited by 189
Zelent, A., Greaves, M., & Enver, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207672 · Cited by 174
Gilliland, D. G., & Tallman, M. S. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00081-8 · Cited by 169
Self-citationMolecular genetics of acute myeloid leukaemia
Dash, A., & Gilliland, D. G. (2001) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2000.0115 · Cited by 166
Self-citationMaternal and neonatal phytoestrogens in Japanese women during birth
Adlercreutz, H., Yamada, T., Wähälä, K., & Watanabe, S. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70281-4 · Cited by 164
Gamis, A. S., Woods, W. G., Alonzo, T. A., Buxton, A., Lange, B., Barnard, D. R., Gold, S., & Smith, F. O. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.060 · Cited by 161
Gilliland, D. G. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200107000-00001 · Cited by 161
Self-citationMechanisms controlling pathogenesis and survival of leukemic stem cells
Jordan, C. T., & Guzmán, M. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207935 · Cited by 154
Self-citationHolyoake, T. L., Jiang, X., Jørgensen, H. G., Graham, S. M., Alcorn, M. J., Laird, C., Eaves, A. C., & Eaves, C. J. (2001) · Blood · doi:10.1182/blood.v97.3.720 · Cited by 152
Smith, M. T., Wang, Y., Skibola, C. F., Slater, D. J., Nigro, L. L., Nowell̀, P. C., Lange, B. J., & Felix, C. A. (2002) · Blood · doi:10.1182/blood-2001-12-0264 · Cited by 141
Self-citationSnyder, R. D., & Gillies, P. J. (2002) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10121 · Cited by 140
Holyoake, T. L., Jiang, X., Drummond, M. W., Eaves, A., & Eaves, C. J. (2002) · Leukemia · doi:10.1038/sj.leu.2402444 · Cited by 139
Doerge, D. R., Churchwell, M. I., Chang, H. C.-W., Newbold, R. R., & Delclos, K. B. (2001) · Reproductive Toxicology · doi:10.1016/s0890-6238(01)00108-3 · Cited by 119
Feuring‐Buske, M., Frankel, A. E., Alexander, R. L., Gerhard, B., & Hogge, D. E. (2002) · PubMed · Cited by 113
Tomasson, M. H., Sternberg, D., Williams, I. R., Carroll, M. P., Cain, D., Aster, J. C., Ilaria, R. L., Etten, R. A. V., & Gilliland, D. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8902 · Cited by 111
Self-citationSohal, J., Phan, V. T., Chan, P. V., Davis, E. M., Patel, B., Kelly, L. M., Abrams, T. J., O'Farrell, A. M., Gilliland, D. G., Beau, M. M. L., et al. (2003) · Blood · doi:10.1182/blood-2002-06-1800 · Cited by 110
Self-citationSabourin, M., & Osheroff, N. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.9.1947 · Cited by 105
Human acute myeloid leukemia stem cells
Hope, K. J., Jin, L., & Dick, J. E. (2003) · Archives of Medical Research · doi:10.1016/j.arcmed.2003.08.007 · Cited by 103
Ailles, L., Gerhard, B., & Hogge, D. E. (1997) · Blood · doi:10.1182/blood.v90.7.2555 · Cited by 99
Histone deacetylases and transcriptional therapy with their inhibitors
Pandolfi, P. P. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100322 · Cited by 82
Considerations for Targeting Malignant Stem Cells in Leukemia
Guzmán, M. L., & Jordan, C. T. (2004) · Cancer Control · doi:10.1177/107327480401100216 · Cited by 82
Self-citationApoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division.
Betti, C. J., Villalobos, M. J., Dı́az, M. O., & Vaughan, A. T. (2003) · PubMed · Cited by 73
The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro
Constantinou, A. I., Stoner, G. D., Mehta, R., Rao, K., Runyan, C. E., & Moon, R. (1995) · Nutrition and Cancer · doi:10.1080/01635589509514368 · Cited by 65
Whitmarsh, R. J., Saginario, C., Zhuo, Y., Hilgenfeld, E., Rappaport, E. F., Megonigal, M. D., Carroll, M. P., Liu, M., Osheroff, N., Cheung, N. V., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1207052 · Cited by 62
Self-citationRecurrence of OTT–MAL fusion in t(1;22) of infant AML‐M7
Mercher, T., Coniat, M. L., Nguyen‐Khac, F., Ballerini, P. F., Mauchauffé, M., Bui, H., Pellegrino, B., Radford‐Weiss, I., Valensi, F., Mugneret, F., et al. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1208 · Cited by 60
Raffini, L. J., Slater, D. J., Rappaport, E. F., Nigro, L. L., Cheung, N. V., Biegel, J. A., Nowell̀, P. C., Lange, B. J., & Felix, C. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062066799 · Cited by 54
Self-citationGe, Y., Jensen, T. L., Matherly, L. H., & Taub, J. W. (2003) · Blood · doi:10.1182/blood-2002-07-2337 · Cited by 52
Guzman, M. L., Upchurch, D., Grimes, B., Howard, D. S., Rizzieri, D. A., Luger, S. M., Phillips, G. L., & Jordan, C. T. (2001) · Blood · doi:10.1182/blood.v97.7.2177 · Cited by 45
Self-citationRapid evaluation of topoisomerase inhibitors: Caffeine inhibition of topoisomerases in vivo
Shin, C., Strayer, J. M., Wani, M. A., & Snapka, R. M. (1990) · Teratogenesis Carcinogenesis and Mutagenesis · doi:10.1002/tcm.1770100106 · Cited by 37
Acute Lymphoblastic Leukemia in Infants
Pui, C., & Evans, W. E. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.438 · Cited by 35
Cited by
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
Pui, C.-H., Carroll, W. L., Meshinchi, S., & Arceci, R. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7405 · Cited by 842
Schnittger, S., Schoch, C., Kern, W., Mecucci, C., Tschulik, C., Martelli, M. F., Haferlach, T., Hiddemann, W., & Falini, B. (2005) · Blood · doi:10.1182/blood-2005-06-2248 · Cited by 713
Mechanisms of Stem Cell Self-Renewal
Shenghui, H., Nakada, D., & Morrison, S. J. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113248 · Cited by 603
Falini, B., Nicoletti, I., Martelli, M. F., & Mecucci, C. (2007) · Blood · doi:10.1182/blood-2006-07-012252 · Cited by 565
Metadata
- Authors
- Gilliland, D. G., Jordan, C. T., & Felix, C. A.
- Venue
- Hematology
- Publisher
- American Society of Hematology
- Published
- 2004-01-01
- Volume
- 2004
- Issue
- 1
- Pages
- 80-97
- ISSN
- 1520-4383 (ISSN-L)
- 1520-4391
- OpenAlex
- W2157305385
- Cited by
- 273
- References
- 77
- FWCI
- 11.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.